TRIM24 and ovarian carcinoma: Breast cancer (33%), ovarian cancer (19%), and lymphomas (14%) were the most frequent malignancies reported by Oldroyd et al. The study showed a significantly higher frequency of ovarian cancer in anti-TIF1-positive vs negative cases (19% vs 2%, respectively) [41].